A randomized controlled trial of fluoxetine in the treatment of cocaine dependence among methadone-maintained patients

Journal of Substance Abuse Treatment

Volumn 40, Issue 3, 2011, Pages 255-264

  Winstanley, Erin L ^a,b   Bigelow, George E ^c   Silverman, Kenneth ^c   Johnson, Rolley E ^c,d   Strain, Eric C ^c  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b Linder Center of Hope   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d RECKITT BENCKISER   (United Kingdom)

Author keywords

Cocaine; Contingency management; Fluoxetine; Methadone

Indexed keywords

FLUOXETINE; METHADONE; PLACEBO;

ADULT; ARTICLE; COCAINE DEPENDENCE; DOUBLE BLIND PROCEDURE; DREAMING; DRUG EFFICACY; DRUG WITHDRAWAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METHADONE TREATMENT; NERVOUSNESS; OPIATE ADDICTION; OUTPATIENT CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; TREATMENT DURATION; TREATMENT OUTCOME; TREMOR; URINALYSIS; XEROSTOMIA;

ADULT; COCAINE-RELATED DISORDERS; DOUBLE-BLIND METHOD; FEMALE; FLUOXETINE; HUMANS; MALE; METHADONE; MIDDLE AGED; MOTIVATION; NARCOTICS; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; SEROTONIN UPTAKE INHIBITORS; SUBSTANCE ABUSE DETECTION; TIME FACTORS; TOKEN ECONOMY; TREATMENT OUTCOME;

EID: 79952439185     PISSN: 07405472     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsat.2010.11.010     Document Type: Article

References (31)

1. Batki S.L., Manfredit L.B., Jacob P., Jones R.T. Fluoxetine for cocaine dependence in methadone maintenance: Quantitative plasma and urine cocaine/benzoylecgonine concentrations. Journal of Clinical Psychopharmacology 1993, 13:243-250.
2. Batki S.L., Washburn A.W., Delucchi K., Jones R.T. A controlled trial of fluoxetine in crack cocaine dependence. Drug and Alcohol Dependence 1996, 41:137-142.
3. Beck A.T., Ward C.H., Mendelson M., Mock J., Erbaugh J. An inventory for measuring depression. Archives of General Psychiatry 1961, 4:561-571.
4. Brower K.K., Carey T.L. Racially related health disparities and alcoholism treatment outcomes. Alcoholism, Clinical and Experimental Research 2003, 27:1365-1367.
5. Carroll M.E., Lac S.T., Asencio M., Kraph R. Fluoxetine reduces intravenous cocaine self-administration in rates. Pharmacol Biochem Behav 1990, 35:237-344.
6. Covi P.T., Hess J.M., Kreiter N.A., Haertzen C.A. Effects of combined fluoxetine and counseling in the outpatient treatment of cocaine abusers. Am J Drug Alcohol Abuse 1995, 21:327-344.
7. de Lima M.S., de Oliveira Soares B.G., Pereira Reisser A.A., Farrell M. Pharmacological treatment for cocaine dependence: a systematic review. Addiction 2002, 97:931-949.
8. Durta L., Stathopoulou G., Basden S.L., Leyro T.M., Powers M.B., Otto M.W. A meta-analytic review of psychosocial interventions for substance use disorders. The American Journal of Psychiatry 2008, 165:179-187.
9. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured Clinical Interview for DSM-IV Axis I Disorders-Patient Edition (SCID-I/P, Version 2.0) 2002, Biometrics Research Department, New York State Psychiatric Institute, New York, NY.
10. Fitzmauice G.M., Laird N.M., Ware J.H. Applied longitudinal data analysis 2004, John Wiley & Sons, Inc, Hoboken, NJ.
11. Grabowski J., Rhoades H., Elk R., Schmitz J., David C., Creson D., et al. Fluoxetine is ineffective for treatment of cocaine dependence or concurrent opiate and cocaine dependence: Two placebo-controlled, double-blind trials. Journal of Clinical Psychopharmacology 1995, 15:163-174.
12. Grella C.E., Hser Y., Joshi V., Anglin M.D. Patient histories, retention, and outcome models for younger and older adults in DATOS. Drug and Alcohol Dependence 1999, 57:151-166.
13. Higgins S.T., Delaney D.D., Budney A.J., Bickel W.K., Hughes J.R., Foerg F., et al. A behavioral approach to achieving initial cocaine abstinence. The American Journal of Psychiatry 1991, 148:1218-1224.
14. Hoehn-Saric R., Lipsey J.R., McLeod D.R. Apathy and indifference in patients on fluvoxamine and fluoxetine. Journal of Clinical Psychopharmacology 1990, 10:343-345.
15. Hser Y., Stark M.E., Paredes A., Huang D., Anglin M.D., Rawson R. A 12-year follow-up of a treated cocaine-dependent sample. Journal of Substance Abuse Treatment 2006, 30:219-226.
16. Koob G.F., Caine S.B. Cocaine addiction therapy-are we partially there?. Nature Med 1999, 5:993-996.
17. Kosten T.A., Kosten T.R., Gawin F.H., Gordon L.T., Hogan I., Kleber H.D. An open trial of sertraline for cocaine abuse. Am J Addict 1992, 1:349-353.
18. McLellan A.T., Luborsky L., Woody G.E., O'Brien C.P. An improved diagnostic evaluation for substance abuse patients: The Addiction Severity Index. The Journal of Nervous and Mental Disease 1980, 168:26-33.
19. Moeller F.G., Schmitz J.M., Steinberg J.L., Green C.M., Reist C., Lai L.Y., et al. Citalopram combined with behavioral therapy reduces cocaine use: A double-blind, placebo-controlled trial. The American Journal of Drug and Alcohol Abuse 2007, 33:367-378.
20. Oliveto A., Kosten T.R., Schottenfeld R., Falcioni J., Ziedonis D. Desipramine, amantadine, or fluoxetine in buprenorphine-maintained cocaine users. J Subst Abuse Treatment 1995, 12:423-428.
21. Pilla M., Perachon S., Sautel F., Garrido F., Mann A., Wermuth C.G., et al. Selective inhibition of cocaine-seeking behaviour by a partial dopamine D3 receptor agonist. Nature 1999, 400:371-375.
22. Prendergast M., Podus D., Finney J., Greenwall L., Roll J. Contingency management for treatment of substance use disorders: A meta-analysis. Addiction 2006, 101:1546-1560.
23. Preston K.L., Silverman K., Schuster C.R., Cone E.J. Assessment of cocaine use with quantitative urinalysis and estimation of new uses. Addiction 1997, 27:717-727.
24. Schmitz J.M., Rhoades H.M., Elk R., Creson D., Hussein I., Grabowski J. Medication take-home doses and contingency management. Experimental and Clinical Psychopharmacology 1998, 6:162-168.
25. Somoza E., Somoza P., Lewis D., Li S.H., Winhusen T., Chiang N., et al. The SRPHK1 outcomes measure for cocaine-dependence trials combines self-report, urine benzoylecgonine levels, and the concordance between the two to determine a cocaine-use status for each study day. Drug and Alcohol Dependence 2008, 93:132-140.
26. Spielberger C.D. State-Trait Inventory for Adults 1983, Mind Garden, Redwood City, VA.
27. Spybrook J., Raudenbush S.W., Liu X., Congdon R., Martinez A. Optimal design for longitudinal and multilevel research: Documentation for the "Optimal Design" Software 2008.
28. Tuchman E. Women and addiction: The importance of gender issues in substance abuse research. Journal of Addictive Diseases 2010, 29:127-138.
29. Vocci F.J., Acri J., Elkashef A. Medication development for addictive disorders: The state of the science. Am J Psychiatry 2005, 162:1432-1440.
30. Walsh S.L., Preston K.L., Sullivan J.T., Fromme R., Bigelow G.E. Fluoxetine alters the effects of intravenous cocaine in humans. Journal of Clinical Psychopharmacology 1994, 14:396-407.
31. Winstanley E.L., Strain E.C., Bigelow G.E. Lack of efficacy of fluoxetine in depressed cocaine dependent subjects. College on the Problems of Drug Dependence 2008.